Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Sep. 30, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 1,345,301	$ 3,258,058
Prepaid expenses and other current assets	506,574	564,645
Inventories	4,126,988	3,713,215
Advances on contracts	1,414,702	1,275,260
Total current assets	8,110,101	9,286,554
Furniture, fixtures and equipment, net	18,254	12,921
Intangibles, net	96,039	148,404
Right of use assets finance lease	59,228	67,201
Right of use assets operating lease	178,251	257,842
Other assets	24,150	24,150
Total assets	8,486,023	9,797,072
Current liabilities:
Current portion of finance lease liabilities	23,919	12,530
Current portion of operating lease liabilities	126,722	116,279
Total current liabilities	5,033,531	3,744,127
Non-current portion of finance lease liabilities	34,170	54,672
Non-current portion of operating lease liabilities	68,927	165,573
Convertible notes payable, related parties	800,000
Total liabilities	5,936,628	3,964,372
Commitments and contingencies
Stockholders’ equity
Common stock, par value $0.001; authorized 100,000,000 shares; 78,592,480 shares issued and 78,559,147 shares outstanding as of September 30, 2025; 78,047,798 shares issued and 78,014,465 shares outstanding as of December 31, 2024;	78,592	78,048
Additional paid in capital	136,067,080	134,719,274
Accumulated deficit	(132,684,761)	(128,053,106)
Treasury stock, at cost, 33,333 shares	(911,516)	(911,516)
Total Milestone Scientific, Inc. stockholders’ equity	2,549,395	5,832,700
Total liabilities and stockholders’ equity	8,486,023	9,797,072
Nonrelated Party [Member]
Current assets:
Accounts receivable	706,924	475,376
Current liabilities:
Accounts payable	2,012,867	1,021,393
Accrued expenses	1,179,893	1,796,319
Related Party [Member]
Current assets:
Accounts receivable	9,612
Current liabilities:
Accounts payable	1,027,360	493,313
Accrued expenses	$ 662,770	$ 304,293